Exponent Inc (EXPO): who owns it and who trades it
As of Nov 16, 2026, EXPO insiders reported 23 open-market sales worth $3.1M and 1 purchase worth $12.6K in the last 12 months, with 71% of the sale value made under pre-set 10b5-1 plans. The largest seller was Catherine Corrigan (CEO), with $2.2M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Exponent
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns EXPO
340 funds and institutions reported EXPO shares worth $2.8B at the end of Q2 2026, about 97% of the company. The largest holder is BlackRock, Inc. with 12.7%.
Funds and institutions (13F) 97%Everyone else 3%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 6.18M | 12.75% | $363M | +2% |
| Kayne Anderson Rudnick Investment Management LLC | 4.00M | 8.24% | $235M | +3% |
| Vanguard Portfolio Management LLC | 3.14M | 6.48% | $185M | +7% |
| Vanguard Capital Management LLC | 2.18M | 4.49% | $128M | -1% |
| State Street Corp | 1.94M | 4.01% | $114M | +3% |
| Geode Capital Management, LLC | 1.75M | 3.60% | $103M | +6% |
| Geneva Capital Management LLC | 1.41M | 2.90% | $82.6M | -22% |
| Royce & Associates LP | 1.32M | 2.73% | $77.7M | +16% |
| Conestoga Capital Advisors, LLC | 1.27M | 2.61% | $74.4M | -34% |
| Morgan Stanley | 1.21M | 2.50% | $71.3M | +13% |
| AQR Capital Management LLC | 1.14M | 2.36% | $67.3M | +17% |
| First Trust Advisors LP | 1.08M | 2.23% | $63.7M | +12% |
| Two Sigma Investments, LP | 1.03M | 2.13% | $60.7M | -6% |
| Dimensional Fund Advisors LP | 927,545 | 1.91% | $54.5M | +1% |
| Norges Bank | 883,843 | 1.82% | $51.9M | – |
| Resona Asset Management Co.,Ltd. | 754,256 | 1.55% | $44.5M | +9% |
| Northern Trust Corp | 648,042 | 1.34% | $38.1M | -2% |
| Wells Fargo & Company | 567,909 | 1.17% | $33.4M | -7% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 559,546 | 1.15% | $32.9M | +8% |
| Invesco Ltd. | 533,719 | 1.10% | $31.4M | -7% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, EXPO insiders reported $12.6K of open-market purchases and $3.1M of sales. 71% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Richard Reiss | Vice president | Sale | 1,280 | $86.44 | $111K | Form 4 |
| Sep 18, 2026 | Shukri Jeries Souri | Vice president | Purchase | 184 | $68.45 | $12.6K | Form 4 |
| Aug 17, 2026 | Catherine Corrigan | CEO | Sale plan | 1,707 | $66.28 | $113K | Form 4 |
| Jul 15, 2026 | Catherine Corrigan | CEO | Sale plan | 1,737 | $62.78 | $109K | Form 4 |
| Jun 15, 2026 | Catherine Corrigan | CEO | Sale plan | 1,793 | $57.13 | $102K | Form 4 |
| Jun 15, 2026 | Catherine Corrigan | CEO | Sale plan | 2,326 | $57.13 | $133K | Form 4 |
| May 26, 2026 | Bradley A James | Vice president | Sale | 2,000 | $57.47 | $115K | Form 4 |
| May 19, 2026 | Richard Reiss | Vice president | Sale | 1,672 | $58.65 | $98.1K | Form 4 |
| May 15, 2026 | Catherine Corrigan | CEO | Sale plan | 1,827 | $54.06 | $98.8K | Form 4 |
| May 15, 2026 | Catherine Corrigan | CEO | Sale plan | 2,367 | $54.06 | $128K | Form 4 |
| May 13, 2026 | Joseph Rakow | Vice president | Sale | 2,945 | $54.66 | $161K | Form 4 |
| May 13, 2026 | Joseph Sala | Vice president | Sale | 2,066 | $56.66 | $117K | Form 4 |
| Apr 15, 2026 | Catherine Corrigan | CEO | Sale plan | 1,697 | $67.70 | $115K | Form 4 |
| Apr 15, 2026 | Catherine Corrigan | CEO | Sale plan | 2,212 | $67.70 | $150K | Form 4 |
| Mar 16, 2026 | Catherine Corrigan | CEO | Sale plan | 2,214 | $67.49 | $149K | Form 4 |
| Mar 16, 2026 | Catherine Corrigan | CEO | Sale plan | 1,698 | $67.49 | $115K | Form 4 |
| Feb 17, 2026 | Catherine Corrigan | CEO | Sale plan | 1,702 | $67.14 | $114K | Form 4 |
| Feb 17, 2026 | Catherine Corrigan | CEO | Sale plan | 2,218 | $67.16 | $149K | Form 4 |
| Feb 10, 2026 | John Pye | Vice president | Sale | 3,659 | $75.98 | $278K | Form 4 |
| Feb 10, 2026 | John Pye | Vice president | Sale | 341 | $75.94 | $25.9K | Form 4 |
| Jan 15, 2026 | Catherine Corrigan | CEO | Sale plan | 1,663 | $72.52 | $121K | Form 4 |
| Dec 15, 2025 | Catherine Corrigan | CEO | Sale plan | 3,225 | $70.74 | $228K | Form 4 |
| Nov 17, 2025 | Catherine Corrigan | CEO | Sale plan | 1,675 | $70.74 | $118K | Form 4 |
| Nov 17, 2025 | Catherine Corrigan | CEO | Sale plan | 3,225 | $70.21 | $226K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Catherine Corrigan | President & CEO, Director | – | $2.2M | Aug 17, 2026 |
| John Pye | VP Global Offices & Innovation | – | $304K | Feb 10, 2026 |
| Richard Reiss | Group Vice President | – | $209K | Nov 3, 2026 |
| Joseph Rakow | Group Vice President | – | $161K | May 13, 2026 |
| Joseph Sala | Group Vice President | – | $117K | May 13, 2026 |
| Bradley A James | Group Vice President | – | $115K | May 26, 2026 |
| Shukri Jeries Souri | Group Vice President | $12.6K | – | Sep 18, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
EXPO short interest
Moderate short interest. 5.1% of EXPO shares are sold short: about 1 share in 20. Over the last 12 reports the number of shares short went down 21%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 2.42M EXPO shares were sold short, 5.1% of the shares outstanding, down 15.7% from the report before. At the average daily volume of 598,938 shares, buying them all back would take about 4.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 2.42M | 5.09% | -16% | 598,938 | 4.0 |
| Oct 15, 2026 | 2.87M | 6.04% | +6% | 574,328 | 5.0 |
| Sep 30, 2026 | 2.71M | 5.71% | -12% | 617,168 | 4.4 |
| Sep 15, 2026 | 3.08M | 6.48% | +4% | 454,024 | 6.8 |
| Aug 31, 2026 | 2.96M | 6.22% | -1% | 350,897 | 8.4 |
| Aug 14, 2026 | 2.99M | 6.29% | +0% | 383,619 | 7.8 |
| Jul 31, 2026 | 2.98M | 6.26% | +2% | 642,341 | 4.6 |
| Jul 15, 2026 | 2.93M | 6.04% | +2% | 498,773 | 5.9 |
| Jun 30, 2026 | 2.87M | 5.92% | +6% | 729,429 | 3.9 |
| Jun 15, 2026 | 2.72M | 5.60% | +33% | 604,041 | 4.5 |
| May 29, 2026 | 2.05M | 4.22% | -34% | 553,097 | 3.7 |
| May 15, 2026 | 3.08M | 6.35% | -4% | 549,275 | 5.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded EXPO
Since Nov 17, 2024, 2 members of Congress reported 3 purchases and 2 sales of EXPO. The latest was a sale by Lisa C. McClain on Sep 11, 2025, reported Oct 22, 2025.
Purchases 3Sales 2
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Sep 11, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Oct 22, 2025 | Report |
| Aug 13, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Sep 12, 2025 | Report |
| May 12, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | Jun 22, 2025 | Report |
| Mar 13, 2025 | Jefferson Shreve (R-IN) | Purchase | $15K–$50K | Self | Apr 11, 2025 | Report |
| Feb 24, 2025 | Jefferson Shreve (R-IN) | Purchase | $15K–$50K | Self | Mar 9, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Exponent company events
Exponent filed 6 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 29, 2026.
- Oct 29, 2026ResultsReleased financial results. Filing
- Jul 30, 2026ResultsReleased financial results. Filing
- Jun 10, 2026VoteReported shareholder vote results. Filing
- Apr 30, 2026ResultsReleased financial results. Filing
- Apr 6, 2026LeadershipExponent, Inc.’s board of directors appointed Dr. Pye as its President, effective as of May 1, 2026. Filing
- Feb 5, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Exponent financials
Famous investors that hold EXPO
5 of the 50 well-known investors we track reported holding EXPO in their latest 13F filing. The largest position is Steve Cohen's, worth $78.1M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Steve Cohen · Point72 Asset Management | Q3 2026 | 1.19M | $78.1M | 0.1% | +203% |
| Israel Englander · Millennium Management | Q3 2026 | 205,277 | $13.4M | 0.0% | -48% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 99,186 | $6.5M | 0.0% | +146% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 31,300 | $2M | 0.0% | New |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 11,419 | $747K | 0.0% | +52% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Exponent Inc (EXPO) stock
Who owns the most EXPO stock?
The largest reported owner of Exponent Inc (EXPO) is BlackRock, Inc., with 12.7% of the company. In total, 340 funds and institutions reported holding EXPO at the end of Q2 2026, together about 97% of the shares. See the largest owners.
Are EXPO insiders buying or selling?
In the last 12 months, EXPO insiders reported 1 open-market purchase worth $12.6K and 23 sales worth $3.1M. The latest trade was on Nov 3, 2026. See every trade.
What is the short interest in EXPO?
As of Oct 30, 2026, 2.42M EXPO shares were sold short, 5.1% of the shares outstanding, down 15.7% from the report before. At the average daily volume of 598,938 shares, buying them all back would take about 4.0 trading days (days to cover). See the history.
Have members of Congress traded EXPO?
Yes. 2 members of Congress reported 3 purchases and 2 sales of EXPO since Nov 17, 2024. The latest was reported on Oct 22, 2025. See the trades.
Which famous investors hold EXPO?
5 of the 50 well-known investors we track reported EXPO in their latest 13F filing, including Steve Cohen, Israel Englander, Ken Griffin. The largest position is worth $78.1M. See all holders.
Executive pay
Exponent's chief executive was paid a total of $3.7M for the year ended Jan 2, 2026, up 7% from $3.5M the year before. In the last 12 months, Exponent's executives and directors bought $12.6K of stock on the open market and sold $3.1M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.